Zobrazeno 1 - 5
of 5
pro vyhledávání: '"T I De Vries"'
Autor:
T I De Vries, J W Eikelboom, J Bosch, J Westerink, J A N Dorresteijn, M Alings, L Dyal, S D Berkowitz, Y Van Der Graaf, K A A Fox, F L J Visseren
Publikováno v:
European Heart Journal. 40
Background The Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial has demonstrated that adding low-dose rivaroxaban to aspirin in patients with stable atherosclerotic disease on average reduces recurrence of cardiovas
Publikováno v:
European Heart Journal. 40
Background The Action for Health in Diabetes trial (Look AHEAD) randomized overweight and obese patients with type 2 diabetes to either an intensive lifestyle intervention (ILI) or diabetes support and education (DSE). The trial was stopped early for
Autor:
Y. van der Graaf, T I De Vries, Peter J. Blankestijn, Frank L.J. Visseren, H A H Kaasjager, Wilko Spiering, A C J Vendeville
Publikováno v:
European Heart Journal. 39
Autor:
Y. van der Graaf, Marielle H. Emmelot-Vonk, J A N Dorresteijn, Christopher J. Bulpitt, Nigel Beckett, T I De Vries, Ruth Peters, Jan Westerink, Majon Muller, Frank L.J. Visseren
Publikováno v:
European Heart Journal. 39
Autor:
H. W. de Valk, G.J. de Borst, T I De Vries, Frank L.J. Visseren, Hendrik M. Nathoe, Jan Westerink, Y. van der Graaf, L. J. Kappelle
Publikováno v:
Acta Diabetologica
Acta Diabetologica, 56(4), 431. Springer-Verlag Italia
Acta Diabetologica, 56(4), 431. Springer-Verlag Italia
Aim To evaluate the relationship between thyroid-stimulating hormone (TSH) levels within the normal range and the risk of type 2 diabetes mellitus (T2DM) in a cohort of patients at high cardiovascular risk, and to perform a systematic review and meta